| 臺大學術典藏 |
2022-09-15T01:08:52Z |
Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)
|
Bang Y.-J.; Golan T.; Dahan L.; Fu S.; Moreno V.; Park K.; Geva R.; De Braud F.; Wainberg Z.A.; Reck M.; Goff L.; Laing N.; Mi G.; Oliveira J.M.; Wasserstrom H.; Chia-Chi Lin |
| 臺大學術典藏 |
2022-09-15T01:08:46Z |
Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors
|
Park K.; Tan D.S.W.; Su W.-C.; Cho B.C.; Kim S.-W.; Lee K.H.; Wang C.-C.; Seto T.; Huang D.C.-L.; Jung H.H.; Hsu M.-C.; Bogenrieder T.; Chia-Chi Lin |
| 臺大學術典藏 |
2022-08-10T02:37:41Z |
EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: Outcomes in Asian populations
|
Kim E.S.; Melosky B.; Park K.; Yamamoto N.; CHIH-HSIN YANG |
| 臺大學術典藏 |
2022-08-10T02:37:39Z |
Amivantamab in egfr exon 20 insertion- mutated non-small-cell lung cancer progressing on platinum chemotherapy: Initial results from the chrysalis phase i study
|
Park K.; Haura E.B.; Leighl N.B.; Mitchell P.; Shu C.A.; Girard N.; Viteri S.; Han J.-Y.; Kim S.-W.; Lee C.K.; Sabari J.K.; Spira A.I.; Yang T.-Y.; Kim D.-W.; Lee K.H.; Sanborn R.E.; Trigo J.; Goto K.; Lee J.-S.; CHIH-HSIN YANG; Govindan R.; Bauml J.M.; Garrido P.; Krebs M.G.; Reckamp K.L.; Xie J.; Curtin J.C.; Haddish-Berhane N.; Roshak A.; Millington D.; Lorenzini P.; Thayu M.; Knoblauch R.E.; Cho B.C. |
| 臺大學術典藏 |
2022-06-27T07:00:23Z |
First-line erlotinib therapy until and beyond response evaluation criteria in solid tumors progression in Asian patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer the ASPIRATION study
|
Park K.; CHONG-JEN YU; Kim S.-W.; Lin M.-C.; Sriuranpong V.; Tsai C.-M.; Lee J.-S.; Kang J.-H.; Chan K.C.A.; Perez-Moreno P.; Button P.; Ahn M.-J.; Mok T. |
| 臺大學術典藏 |
2022-06-27T06:59:45Z |
Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC
|
Nishio M.; Felip E.; Orlov S.; Park K.; CHONG-JEN YU; Tsai C.-M.; Cobo M.; McKeage M.; Su W.-C.; Mok T.; Scagliotti G.V.; Spigel D.R.; Viraswami-Appanna K.; Chen Z.; Passos V.Q.; Shaw A.T. |
| 臺大學術典藏 |
2022-06-27T06:59:36Z |
Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study
|
Park K.; J?nne P.A.; Kim D.-W.; Han J.-Y.; Wu M.-F.; Lee J.-S.; Kang J.-H.; Lee D.H.; Cho B.C.; CHONG-JEN YU; Pang Y.K.; Felip E.; Kim H.; Baek E.; Noh Y.S. |
| 臺大學術典藏 |
2022-03-22T08:29:32Z |
Human platelet lysate (hPL) alters the lineage commitment and paracrine functions of human mesenchymal stem cells via mitochondrial metabolism
|
Du P;Tao X;Liu K;Lin J;Shi Y;Park K;Chen H.-Y;Lin C.-P;Chang J;Wong R.C;Pan H;Wang P.-Y.; Chen H.-Y; HSIEN-YEH CHEN et al. |
| 臺大學術典藏 |
2022-03-22T08:29:32Z |
Human platelet lysate (hPL) alters the lineage commitment and paracrine functions of human mesenchymal stem cells via mitochondrial metabolism
|
Du P;Tao X;Liu K;Lin J;Shi Y;Park K;Chen H.-Y;Lin C.-P;Chang J;Wong R.C;Pan H;Wang P.-Y.; Chen H.-Y; HSIEN-YEH CHEN et al. |
| 臺大學術典藏 |
2022-03-22T08:26:39Z |
Human platelet lysate (hPL) alters the lineage commitment and paracrine functions of human mesenchymal stem cells via mitochondrial metabolism
|
Du P;Tao X;Liu K;Lin J;Shi Y;Park K;Chen H.-Y;Lin C.-P;Chang J;Wong R.C;Pan H;Wang P.-Y.; Chen H.-Y; HSIEN-YEH CHEN et al. |
| 臺大學術典藏 |
2022-03-07T07:05:29Z |
Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia
|
Kawarada O.; Hozawa K.; Zen K.; Huang H.-L.; Kim S.H.; Choi D.; Park K.; Kato K.; Kato T.; Tsubakimoto Y.; Ichihashi S.; Fujimura N.; Higashimori A.; Sato T.; Yan B.P.-Y.; Pang S.Y.-C.; Wongwanit C.; Leong Y.P.; Chua B.; George R.K.; Chen I.-C.; JEN-KUANG LEE; Hsu C.-H.; Pua U.; Iwata Y.; Miki K.; Okada K.; Obara H. |
| 臺大學術典藏 |
2022 |
Tolerability and efficacy of durvalumab, either as monotherapy or in combination with tremelimumab, in patients from Asia with advanced biliary tract, esophageal, or head-and-neck cancer
|
Doki Y.; Ueno M.; CHIH-HUNG HSU; Oh D.-Y.; Park K.; Yamamoto N.; Ioka T.; Hara H.; Hayama M.; Nii M.; Komuro K.; Sugimoto M.; Tahara M. |
| 臺大學術典藏 |
2021-11-03T02:32:59Z |
RELAY subgroup analyses by EGFR Ex19del and Ex21L858R mutations for ramucirumab plus erlotinib in metastatic non?small cell lung cancer
|
Nakagawa K.; Nadal E.; Garon E.B.; Nishio M.; Seto T.; Yamamoto N.; Park K.; JIN-YUAN SHIH; Paz-Ares L.; Frimodt-Moller B.; Zimmermann A.H.; Wijayawardana S.; Visseren-Grul C.; Reck M. |
| 臺大學術典藏 |
2021-07-21T07:25:27Z |
Pion and kaon structure at the electron-ion collider
|
Aguilar A.C;Ahmed Z;Aidala C;Ali S;Andrieux V;Arrington J;Bashir A;Berdnikov V;Binosi D;Chang L;Chen C;Chen M;de Melo J.P.B.C;Diefenthaler M;Ding M;Ent R;Frederico T;Gao F;Gothe R.W;Hattawy M;Hobbs T.J;Horn T;Huber G.M;Jia S;Keppel C;Krein G;Lin H.-W;Mezrag C;Mokeev V;Montgomery R;Moutarde H;Nadolsky P;Papavassiliou J;Park K;Pegg I.L;Peng J.-C;Platchkov S;Qin S.-X;Raya K;Reimer P;Richards D.G;Roberts C.D;Rodr?guez-Quintero J;Sato N;Schmidt S.M;Segovia J;Tadepalli A;Trotta R;Ye Z;Yoshida R;Xu S.-S.; Aguilar A.C; NOBUO SATO et al. |
| 臺大學術典藏 |
2021-05-02T03:49:13Z |
Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY
|
Nishio M.;Seto T.;Reck M.;Garon E.B.;Chiu C.-H.;Yoh K.;Imamura F.;Park K.;Jin-Yuan Shih;Visseren-Grul C.;Frimodt-Moller B.;Zimmermann A.;Homma G.;Enatsu S.;Nakagawa K.;Relay Study Investigators; Nishio M.; Seto T.; Reck M.; Garon E.B.; Chiu C.-H.; Yoh K.; Imamura F.; Park K.; JIN-YUAN SHIH; Visseren-Grul C.; Frimodt-Moller B.; Zimmermann A.; Homma G.; Enatsu S.; Nakagawa K.; RELAY Study Investigators |
| 臺大學術典藏 |
2021-05-02T03:49:12Z |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
|
Chang G.-C.; Lam D.C.-L.; Tsai C.-M.; Chen Y.-M.; JIN-YUAN SHIH; Aggarwal S.; Wang S.; Kim S.-W.; Kim Y.-C.; Wahid I.; Li R.; Lim D.W.-T.; Sriuranpong V.; Chan R.T.-T.; Lorence R.M.; Carriere P.; Raabe C.; Cseh A.; Park K. |
| 臺大學術典藏 |
2021-05-02T03:29:22Z |
Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study
|
Park K.; J?nne P.A.; Kim D.-W.; Han J.-Y.; Wu M.-F.; Lee J.-S.; Kang J.-H.; Lee D.H.; Cho B.C.; CHONG-JEN YU; Pang Y.K.; Felip E.; Kim H.; Baek E.; Noh Y.S. |
| 臺大學術典藏 |
2021-04-28T04:52:03Z |
Dapagliflozin and cardiovascular outcomes in type 2 diabetes
|
Wiviott S.D.;Swiviott@Bwh.Harvard.Edu, Raz I.;Bonaca M.P.;Mosenzon O.;Kato E.T.;Cahn A.;Silverman M.G.;Zelniker T.A.;Kuder J.F.;Murphy S.A.;Bhatt D.L.;Leiter L.A.;Mcguire D.K.;Wilding J.P.H.;Ruff C.T.;Nilsson G.I.;Fredriksson M.;Johansson P.A.;Langkilde A.M.;Sabatine M.S.;Bansilal S.;Furtado R.;Fish M.P.;Gabovitch D.;Jevne A.;Ahern S.;Im K.;Goodrich E.L.;Lowe C.;Fisher N.;Gannon J.;Trindade S.;Towarowski A.;Fox Y.;Johnsson E.;Ranft S.;Faber B.;Wallander M.;Weiss A.;Buskila A.;Abola M.T.B.;Ardissino D.;Averkov O.;Aylward P.;Bode C.;Bonnici F.;Bonora E.;Budaj A.;Cernea S.;Chiang C.E.;Cooper M.;Dalby A.;Deerochanawong C.;Dellborg M.;Diaz R.;Dimulescu D.;Eliaschewitz F.G.;Goudev A.R.;Hadjadj S.;Herrera M.;Huo Y.;Jermendy G.;Ji L.;Kadowaki T.;Kiss R.;Kooy A.;Kumar K.M.P.;Lewis B.;Litwak L.;Lopez-Sendon J.;Ma R.;Merlini P.A.;Nauck M.A.;Nguyen T.K.;Nicolau J.C.;Ostgren C.J.;Ophuis T.O.;Padilla F.;Pais P.;Park K.S.;Parkhomenko A.;Ray K.;Rosenstock J.;Ruda M.;Satman I.;Shestakova M.;Smahelova A.;Spinar J.;Strojek K.;Sy R.;Tankova T.;Theroux P.;Tk?? I.;Van Gaal L.;Wainstein J.;Harrington R.A.;Droller M.J.;Lee K.L.;Nesto R.W.;Tuomilehto J.;Hedlin H.;Desai M.;Sayfer I.;Alexanian S.;Awtry E.;Bentley-Lewis R.;Berger C.J.;Croce K.;Desai A.;Garg R.K.;Gelfand E.;Gignac G.;Goessling W.;Ho C.;Hochberg E.;Lane A.;Larrey D.;Leeman D.E.;Lewis J.;Link M.S.;Mcdonnell M.E.;Norden A.D.;Pande A.;Rosenberg C.;Rost N.;Ruberg F.;Schiff E.;Silverman S.;Singhal A.;Wagner A.;Wolpin B.;Aizenberg D.;Fern?Ndez M.;Sala J.;Maffei L.;Luquez C.;Waitman J.;Rista L.;Nardone L.;Sposetti G.;Cantero M.;Alvarisqueta A.;Monta?A O.;Cuadrado J.;Cartasegna L.;Baccaro C.;Chertkoff A.;Sanabria H.;Vainstein N.;Amerena J.;Arya K.;D'Emden M.;Proietto J.;Moses R.;Colquhoun D.;Stranks S.;Lehman R.;Hamilton A.;Whelan A.;Simpson R.;Purnell P.;Abhayaratna W.;Hammett C.;Mckeirnan M.;Sullivan D.;Bach L.;Hughes K.;Mathieu C.;Vercammen C.;Scheen A.;Duyck F.;Cools F.;De Wolf L.;Verhaegen A.;Nobels F.;Missault L.;Crenier L.;Thoeng J.;Wollaert B.;Vandenbroucke M.;Eliaschewitz F.;Borges J.L.C.;Turatti L.;Lima F.G.;Dos Santos F.;Kerr Saraiva J.;Pereira M.;Pereira A.;Precoma D.B.;Filho G.F.V.;Reis G.;Maia L.N.;Bacheva T.;Temelkova-Kurktschiev T.;Maneva S.;Stoyanovska B.;Boshnyashka R.;Stoykova Y.;Georgiev D.;Tagarev Z.;Dimitrova E.;Vitkina M.;Yordanova L.;Temelkova M.;Vasileva S.;Kuneva T.;Zyumbyuleva M.;Daskalova I.;Genadieva V.;Boyanov L.;Farah G.;Lazarova G.;Georgieva M.;Krasteva S.;Slavcheva A.;Yabroudi N.;Veleva N.;Zlateva A.;Damyanova V.;Elenkova A.;Kotselova T.;Genov K.;Lyubenova L.;Temelkova N.;Harizanova B.;Zaharieva S.;Bajaj H.;Goldenberg R.;Aronson R.;Twum-Barima D.;Dumas R.;Kouz S.;Kaiser S.M.;Ajala B.;Cha J.;Teitelbaum I.;Chouinard G.;Woo V.;Dan Dattani I.;Mazza G.;Gaudet D.;Poirier P.;Conway J.;Dion D.;Mckeough M.;Manyari D.;Harris S.;St-Pierre B.;Yale J.F.;Landry D.;Gupta M.;Hramiak I.;Lau D.;Degrace M.;Gallo R.;Montigny M.;Dzongowski P.;Liutkus J.;Frechette A.;Gosselin G.;Sabbah E.;Langlois M.F.;Rabasa-Lhoret R.;Bedard J.;Hart R.;Dowell A.;Pandey A.;O'Keefe D.;Hill L.;Weisnagel S.J.;Muirhead N.;Zimmermann R.;Galiwango P.;Tobe S.;Priestman B.;Zinman B.;Ma J.;Zhao X.;Chih-Yuan Wang;Zhang A.;Dong Y.;Dong X.;Luo M.;Guo J.;Zheng Z.;Li Y.;Liang Y.;Peng D.;?Pinar J.;Mad??I? D.;?Mahelov? A.;?Pinarov? L.;Raclavsk? L.;Ludka O.;?Ih??Ek I.;Karasov? J.;Pelik?Nov? M.;Vlas?Kov? H.;Urbancov? K.;Zamrazil V.;Hradec J.;Vla?Icov? H.;Ra?Ick? E.;Ok?Nka L.;N?Plava R.;Skope?Ek J.;P?Lov? S.;Krystl T.;P??T?K Z.;Oznerov? M.;Andresov? A.;?Arbochov? R.;T?Borsk? P.;Petrov? I.;Stan?K L.;Reichert P.;Lorenc Z.;Szab? M.;Petit C.;Krempf M.;Boye A.;Dubois S.;Clavel S.;Gourdy P.;Elbaz M.;Jazayeri S.;Gouet D.;Verges B.;Couffinhal T.;Sendeski M.;Klausmann G.;Appel K.;Pein M.;Thieme R.;Schumm-Draeger P.;Jacob S.;Toursarkissian N.;Kleinecke-Pohl U.;Tsch?Pe D.;Ott P.;Haak T.;Nauck M.;Derwahl K.;Bugger H.;Hui G.;Tsang C.;Zilahi Z.;P?Ski L.;Vangel S.;F?L?P T.;P?Ll K.;Hidv?Gi T.;R?V?Sz K.;Kor?Nyi L.;Kajet?N M.;Ker?Nyi Z.;P?Nzes J.;Herczeg B.;L?Szl?Czky A.;Turi T.;Rapi J.;P?Ntek Z.;Ga?L Z.;Winkler G.;Percs E.;Czig?Ny A.;Harcsa E.;Gurz? M.;Tassaly J.;Horthy R.;Petr? G.;Farag? K.;M?Ller G.;Varju I.;Kirschner R.;Kiss I.;Bakai J.;Kancz S.;Marton Z.;Kodur R.;Yajnik C.;Thomas N.;Ayyar V.;Iyengar P.;Bashkin A.;Daoud D.;Itzhak B.;Katz A.;Tsur A.;Nikolsky E.;Atar S.;Grossman A.;Klainman E.;Tsalihin D.;Shotan A.;Turgeman Y.;Ferrario M.;Merlini P.;Piatti P.;Zenari L.;Trevisan R.;Bosco B.;Di Lorenzo L.;Mannucci E.;Avogaro A.;Reimers B.;Trimarco B.;Silvestri O.;Salvioni A.;Nakagawa H.;Sueyoshi A.;Fukuda K.;Yasumoto H.;Matsubayashi S.;Kawajiri K.;Togashi Y.;Senokuchi T.;Ohta Y.;Yamauchi T.;Node K.;Alcocer Gamba M.;Herrera Marmolejo M.;De Los Rios Ibarra M.;Gonz?Lez G?Lvez G.;Garc?A Cant? E.;Legu?Zamo Dimas A.;Luna Ceballos R.;Medina Pech C.;Stobschinski De Alba C.;Gonz?Lez Gonz?Lez J.;Padilla Padilla F.;Fangh?Nel Salm?N G.;Robles Torres F.;L?Pez Rosas E.;Pelayo Orozco E.;Banda Elizondo R.;Escalona Caama?O A.;Frenk Baron P.;Aguilar Salinas C.;Mustieles Rocha C.;Vidrio Vel?Zquez M.;Rodr?Guez Briones I.;Saldate Alonso M.;Velasco S?Nchez R.;Groenemeijer B.;Ronner E.;Kuijper A.;Strikwerda S.;Van Kempen W.;Gijsbers S.;Oude Ophuis A.;Swart H.;Hoogenberg K.;Hovens M.;Van Hessen M.;Westerink J.;Kragten J.;Nierop P.;Bax W.;Hartong S.;Nieuwdorp M.;Gonkel F.;Al Windy N.;Troquay R.;Schaafsma H.;Lieverse A.;Knufman N.;Tirador L.;Guenon M.;Ferrolino A.;Atilano A.;Aportadera M.;Que M.;Denopol M.;Tolentino M.;Jimeno C.;Wee J.;Mirasol R.;Panelo A.;Roxas D.;Abola M.;Palmes P.;Silva A.;Salvador D.;Rosita R.;Maravilla L.;Rogelio G.;Pacheco E.;Tin Hay L.;Prado J.;Krzy?Ag?Rska E.;Witek R.;Mik?Aszewicz B.;Sudnik W.;Pomie?Ko W.;Bochenek A.;Fares I.;Wujkowski M.;Korol M.;Powier?A S.;Goch A.;Mi?Kus P.;Siegel A.;Skierkowska J.;Roma?Czuk P.;Cygler J.;?Anda K.;Szyprowska E.;Stachlewski P.;Czerski T.;Paw?Owicz L.;Sowi?Ski D.;Romanowski L.;Rudzki H.;Sk?Rski M.;Jasiel-Wojculewicz H.;Stasiewski A.;Kania G.;Mirek-Bryniarska E.;Wojnowski L.;Korzeniak R.;Oh T.;Park K.;Lee M.;Lee K.;Jang H.;Kim S.;Ku B.;Cha B.;Son H.;Lee I.;Park J.;Yu S.;Shon H.;Rhee E.;Cho J.;Park T.;Nam J.;Pintilei E.;Popescu A.;Nafornita V.;Gutu O.;Dumitrescu A.;Bala C.;Caceaune E.;Mindrescu N.;Morosanu M.;Bradescu O.;Munteanu M.;Voitec M.;Vlaiculescu M.;Hancu N.;Diaconu Sotropa M.;Lupu S.;Mateescu A.;Carlan L.;Marton R.;Lupusoru D.;Mot A.;Coman A.;Zaharie D.;Rebrov A.;Shutemova E.;Bolieva L.;Khalimov Y.;Statsenko M.;Galyavich A.;Koziolova N.;Shapovalova Y.;Pavlysh E.;Strongin L.;Vertkin A.;Vishneva E.;Pavlova M.;Khasanov N.;Antsiferov M.;Gavrisheva I.;Sokolova N.;Vorobyev S.;Morugova T.;Sinitsina I.;Ezhov A.;Kobalava Z.;Belenkiy D.;Supryadkina T.;Kazakov Y.;Oschepkova E.;Dreval A.;Novikova T.;Vishnevsky A.;Chizhov D.;Akatova E.;Vorokhobina N.;Ivanov I.;Dudinskaya E.;Konstantinov V.;Kanderkov? D.;Pavl?K L.;Ra?Lov? K.;Paulovi? V.;Bab?Kov? J.;Bele?Ov? K.;Mer?Iakov? M.;Truban J.;Vargov? A.;F?Bryov? L.;Slovensk? M.;Pl??Il R.;Tom??Ov? L.;Koll?Rov? D.;Spodniakov? D.;Ko??Kov? M.;D?Uponov? J.;Kur?Ov? I.;Skripova D.;Gabri?Ov? A.;Kalinov? S.;Ranjith N.;Burgess L.;Mitha I.;Conradie M.;Distiller L.;Pillai P.;Pillay S.;Horak A.;Nethononda R.;Van Den Berg E.;Nortje H.;Bayat J.;Corbett C.;Abelson M.;Van Zyl L.;Pillay T.;Wing J.;Kapp C.;Hidalgo Urbano R.;Gonzalez Juanatey J.;Blanco Coronado J.;Bruguera Cortada J.;Ferreiro Gutierrez J.;Quesada Simon M.;Castro A.;Delgado ?Lvarez E.;Freixa R.;Boada A.;Larnefeldt H.;Mooe T.;Koskinen P.;Lagerb?Ck P.;Linderfalk C.;Liu B.;Berndtsson Blom K.;Tengmark B.;Lindholm C.;?Stgren C.;Oweling M.;Albertsson P.;Alvarsson M.;Fant S.;Berglund O.;Hsia C.;Chiang C.;Fang C.;Ueng K.;Wang K.;Lai W.;Mamanasiri S.;Wongvipaporn C.;Kuanprasert S.;Thongsri T.;Srimahachota S.;Boonyavarakul A.;Suwanwalaikorn S.;Tantiwong P.;Sritara P.;Sriwijitkamol A.;Sanguanwong S.;Chotinaiwattarakul C.;Piyayotai D.;Balci M.;Orbay E.;Saygili F.;Oguz A.;Altuntas Y.;Comlekci A.;Karpenko O.;Tkach S.;Vlasenko M.;Fushtey I.;Pertseva T.;Reshotko D.;Mostovoy Y.;Vizir V.;Kraiz I.;Amosova K.;Batushkin V.;Tseluyko V.;Koval O.;Strang C.;Bodalia B.;Pieters R.;Turner W.;Asamoah-Owusu N.;White C.;Calvert J.;Mcnally D.;Jones N.;Mckaig G.;Thompson J.;Mohr S.;Simpson H.;Conn P.;Mccoye A.;Rivero O.;Yazdani S.;Ince C.;Zeitlin J.;Wharton T.;Platt G.;Anderson R.J.;Angueira-Serrano E.;Lillestol M.;Hanlon B.;Soufer J.;Garcia B.;Iteld B.;Venugopal C.;Ahmed A.;Duardo-Guerra Y.;Jetty P.;Miranda A.;Wahlen J.;Lederman S.;Cohen K.;Lake L.;French W.J.;Tahirkheli N.;Baker S.;Stoltz R.;Wilson J.;Nadar V.;Brown J.;Larrain G.;Wiseman A.;Ruoff G.;Williams M.;Tan A.;Hartman I.;Singh N.;Graf R.;Wakefield P.;Mcneill R.;Byars W.;Reyes Almodovar R.;Jones S.;Kantaros L.;Hegedosh N.;Graves M.;Bernstein M.;Falkowski S.;Bialow M.;Paraschos A.;Dagher G.;Arif A.;Condit J.;Chaykin L.;Grunstra B.;Earl J.;Unks D.;Srivastava S.;Benson M.;Huffman C.;Miller G.;Willis J.;Bender K.;Martin E.;Blackmore R.;Rohr K.;Chilka S.;Gadowski G.;Fitz-Patrick D.;Benjamin S.;Morin D.;Zias Dilena A.;Acosta R.;Claassen D.;Miranda F.;Raad G.;Inzerello A.;Porter J.;Bhattacharya A.;Gutmann J.;Korpas D.;Syed M.;Zieve F.;Raisinghani A.;Alam S.;Bartkowiak A.;Boccalandro F.;Talano J.;Mercado A.;Krichmar P.;Oldfield C.;Adams K.;Gorman T.;Lewis D.;Shah R.;Shockey G.;Lefebvre G.;Andrawis N.;Tami L.;Bittar N.;Khan M.S.;Rink L.;Hendrix E.;Wood J.;Robinson J.;Pavon H.;Irfan M.;Gonzalez E.;Singal R.;Shore K.;Saba F.;Bianco J.;Erickson B.;Gorson D.;Puri S.;Arauz-Pacheco C.;Forman S.;Akyea-Djamson A.;Lieber I.;Barker B.;Desai P.;Sotolongo C.;Steinhoff J.;Hill R.;Radin M.;Patel R.;Lieberman S.;Wenocur H.;Dagogo-Jack S.;Lupovitch S.;Ison R.;Bacharach J.M.;Diogo J.;Mazzella M.;Greenwald J.;Quadrel M.;Mayer N.;Datu J.;Mccartney M.;Bruce T.;Singal D.;Turner J.;Videau B.;Fritz R.;Fox D.;Calatayud G.;Sheldon W.;Kereiakes D.;Thomas J.;Salacata A.;Mccullum K.;Harris B.;De Souza J.;Rahman A.;Blumenthal S.;Narayan P.;Bloch M.;Augenbraun C.;Bernstein R.;Perlman R.;Berman J.;Labryer L.;Wynne A.;Fish J.;Zarich S.;Gabra N.;Popeil L.;Hermany P.;Barreto A.;Pomposini D.;Gonzalez-Campoy J.M.;Langer M.;Bayron C.;Suneja R.;Kamlet J.;Wheeler K.;Hurley S.;Sharma S.;Wefald F.;Hershon K.;O'Connor T.;Pueblitz G.;Laguerre J.;Amin M.;Alfonso T.;Jaffrani N.;Isserman S.;Portnay E.;Vlastaris A.;Dy J.;Hagan M.;Noveck H.;Kraft P.;Andersen J.;Foley B.;Carr K.;Gelormini J.;Williams T.;Landau C.;Richwine R.;Thakkar M.;Karim A.;Madhun Z.;Francyk D.;Lamantia J.;Baker B.;Zhang W.;Lev V.;Hasan M.;Captain A.;Herzog W.;Friedman K.;Lawson W.;Desai V.;Ow C.;Simons R.;Mandviwala M.;Le T.;Hack T.;Zebrack J.;Henderson D.;Dejulia J.;Mehta R.;Reza S.;Poonawala R.;Awad A.;Velasquez M.;Mohiuddin S.;Salazar Sharma M.;Myrick G.;Gottlieb D.;Ovalle F.;Alfieri A.;Ahmed S.;Bohula E.;Donahoe S.M.;Longshaw K.;Eshaghian S.;Lash J.;Goldberg R.K.;Fox B.;Mostel E.;Dobies D.;Ward H.;Burbano J.;Puleo P.;Lenhard M.J.;Korn D.;Thadani U.;Bradley A.;Kmetzo J.;Heasley E.;Raikhel M.;Mahr N.;Bittar G.;Fuentes F.;Raghu P.;Diep T.T.B.;Tran Q.K.;Tran N.;Nguyen D.;Nguy?N V.;Declare-Timi 58 Investigators; Wiviott S.D.; Swiviott@bwh.harvard.edu, Raz I.; Bonaca M.P.; Mosenzon O.; Kato E.T.; Cahn A.; Silverman M.G.; Zelniker T.A.; Kuder J.F.; Murphy S.A.; Bhatt D.L.; Leiter L.A.; McGuire D.K.; Wilding J.P.H.; Ruff C.T.; Nilsson G.I.; Fredriksson M.; Johansson P.A.; Langkilde A.M.; Sabatine M.S.; Bansilal S.; Furtado R.; Fish M.P.; Gabovitch D.; Jevne A.; Ahern S.; Im K.; Goodrich E.L.; Lowe C.; Fisher N.; Gannon J.; Trindade S.; Towarowski A.; Fox Y.; Johnsson E.; Ranft S.; Faber B.; Wallander M.; Weiss A.; Buskila A.; Abola M.T.B.; Ardissino D.; Averkov O.; Aylward P.; Bode C.; Bonnici F.; Bonora E.; Budaj A.; Cernea S.; Chiang C.E.; Cooper M.; Dalby A.; Deerochanawong C.; Dellborg M.; Diaz R.; Dimulescu D.; Eliaschewitz F.G.; Goudev A.R.; Hadjadj S.; Herrera M.; Huo Y.; Jermendy G.; Ji L.; Kadowaki T.; Kiss R.; Kooy A.; Kumar K.M.P.; Lewis B.; Litwak L.; Lopez-Sendon J.; Ma R.; Merlini P.A.; Nauck M.A.; Nguyen T.K.; Nicolau J.C.; Ostgren C.J.; Ophuis T.O.; Padilla F.; Pais P.; Park K.S.; Parkhomenko A.; Ray K.; Rosenstock J.; Ruda M.; Satman I.; Shestakova M.; Smahelova A.; Spinar J.; Strojek K.; Sy R.; Tankova T.; Theroux P.; Tk?? I.; Van Gaal L.; Wainstein J.; Harrington R.A.; Droller M.J.; Lee K.L.; Nesto R.W.; Tuomilehto J.; Hedlin H.; Desai M.; Sayfer I.; Alexanian S.; Awtry E.; Bentley-Lewis R.; Berger C.J.; Croce K.; Desai A.; Garg R.K.; Gelfand E.; Gignac G.; Goessling W.; Ho C.; Hochberg E.; Lane A.; Larrey D.; Leeman D.E.; Lewis J.; Link M.S.; McDonnell M.E.; Norden A.D.; Pande A.; Rosenberg C.; Rost N.; Ruberg F.; Schiff E.; Silverman S.; Singhal A.; Wagner A.; Wolpin B.; Aizenberg D.; Fern?ndez M.; Sala J.; Maffei L.; Luquez C.; Waitman J.; Rista L.; Nardone L.; Sposetti G.; Cantero M.; Alvarisqueta A.; Monta?a O.; Cuadrado J.; Cartasegna L.; Baccaro C.; Chertkoff A.; Sanabria H.; Vainstein N.; Amerena J.; Arya K.; d'Emden M.; Proietto J.; Moses R.; Colquhoun D.; Stranks S.; Lehman R.; Hamilton A.; Whelan A.; Simpson R.; Purnell P.; Abhayaratna W.; Hammett C.; McKeirnan M.; Sullivan D.; Bach L.; Hughes K.; Mathieu C.; Vercammen C.; Scheen A.; Duyck F.; Cools F.; De Wolf L.; Verhaegen A.; Nobels F.; Missault L.; Crenier L.; Thoeng J.; Wollaert B.; Vandenbroucke M.; Eliaschewitz F.; Borges J.L.C.; Turatti L.; Lima F.G.; dos Santos F.; Kerr Saraiva J.; Pereira M.; Pereira A.; Precoma D.B.; Filho G.F.V.; Reis G.; Maia L.N.; Bacheva T.; Temelkova-Kurktschiev T.; Maneva S.; Stoyanovska B.; Boshnyashka R.; Stoykova Y.; Georgiev D.; Tagarev Z.; Dimitrova E.; Vitkina M.; Yordanova L.; Temelkova M.; Vasileva S.; Kuneva T.; Zyumbyuleva M.; Daskalova I.; Genadieva V.; Boyanov L.; Farah G.; Lazarova G.; Georgieva M.; Krasteva S.; Slavcheva A.; Yabroudi N.; Veleva N.; Zlateva A.; Damyanova V.; Elenkova A.; Kotselova T.; Genov K.; Lyubenova L.; Temelkova N.; Harizanova B.; Zaharieva S.; Bajaj H.; Goldenberg R.; Aronson R.; Twum-Barima D.; Dumas R.; Kouz S.; Kaiser S.M.; Ajala B.; Cha J.; Teitelbaum I.; Chouinard G.; Woo V.; Dan Dattani I.; Mazza G.; Gaudet D.; Poirier P.; Conway J.; Dion D.; McKeough M.; Manyari D.; Harris S.; St-Pierre B.; Yale J.F.; Landry D.; Gupta M.; Hramiak I.; Lau D.; DeGrace M.; Gallo R.; Montigny M.; Dzongowski P.; Liutkus J.; Frechette A.; Gosselin G.; Sabbah E.; Langlois M.F.; Rabasa-Lhoret R.; Bedard J.; Hart R.; Dowell A.; Pandey A.; O'Keefe D.; Hill L.; Weisnagel S.J.; Muirhead N.; Zimmermann R.; Galiwango P.; Tobe S.; Priestman B.; Zinman B.; Ma J.; Zhao X.; CHIH-YUAN WANG; Zhang A.; Dong Y.; Dong X.; Luo M.; Guo J.; Zheng Z.; Li Y.; Liang Y.; Peng D.; ?pinar J.; Mad??i? D.; ?mahelov? A.; ?pinarov? L.; Raclavsk? L.; Ludka O.; ?ih??ek I.; Karasov? J.; Pelik?nov? M.; Vlas?kov? H.; Urbancov? K.; Zamrazil V.; Hradec J.; Vla?icov? H.; Ra?ick? E.; Ok?nka L.; N?plava R.; Skope?ek J.; P?lov? S.; Krystl T.; P??t?k Z.; Oznerov? M.; Andresov? A.; ?arbochov? R.; T?borsk? P.; Petrov? I.; Stan?k L.; Reichert P.; Lorenc Z.; Szab? M.; Petit C.; Krempf M.; Boye A.; Dubois S.; Clavel S.; Gourdy P.; Elbaz M.; Jazayeri S.; Gouet D.; Verges B.; Couffinhal T.; Sendeski M.; Klausmann G.; Appel K.; Pein M.; Thieme R.; Schumm-Draeger P.; Jacob S.; Toursarkissian N.; Kleinecke-Pohl U.; Tsch?pe D.; Ott P.; Haak T.; Nauck M.; Derwahl K.; Bugger H.; Hui G.; Tsang C.; Zilahi Z.; P?ski L.; Vangel S.; F?l?p T.; P?ll K.; Hidv?gi T.; R?v?sz K.; Kor?nyi L.; Kajet?n M.; Ker?nyi Z.; P?nzes J.; Herczeg B.; L?szl?czky A.; Turi T.; Rapi J.; P?ntek Z.; Ga?l Z.; Winkler G.; Percs E.; Czig?ny A.; Harcsa E.; Gurz? M.; Tassaly J.; Horthy R.; Petr? G.; Farag? K.; M?ller G.; Varju I.; Kirschner R.; Kiss I.; Bakai J.; Kancz S.; Marton Z.; Kodur R.; Yajnik C.; Thomas N.; Ayyar V.; Iyengar P.; Bashkin A.; Daoud D.; Itzhak B.; Katz A.; Tsur A.; Nikolsky E.; Atar S.; Grossman A.; Klainman E.; Tsalihin D.; Shotan A.; Turgeman Y.; Ferrario M.; Merlini P.; Piatti P.; Zenari L.; Trevisan R.; Bosco B.; Di Lorenzo L.; Mannucci E.; Avogaro A.; Reimers B.; Trimarco B.; Silvestri O.; Salvioni A.; Nakagawa H.; Sueyoshi A.; Fukuda K.; Yasumoto H.; Matsubayashi S.; Kawajiri K.; Togashi Y.; Senokuchi T.; Ohta Y.; Yamauchi T.; Node K.; Alcocer Gamba M.; Herrera Marmolejo M.; De los Rios Ibarra M.; Gonz?lez G?lvez G.; Garc?a Cant? E.; Legu?zamo Dimas A.; Luna Ceballos R.; Medina Pech C.; Stobschinski de Alba C.; Gonz?lez Gonz?lez J.; Padilla Padilla F.; Fangh?nel Salm?n G.; Robles Torres F.; L?pez Rosas E.; Pelayo Orozco E.; Banda Elizondo R.; Escalona Caama?o A.; Frenk Baron P.; Aguilar Salinas C.; Mustieles Rocha C.; Vidrio Vel?zquez M.; Rodr?guez Briones I.; Saldate Alonso M.; Velasco S?nchez R.; Groenemeijer B.; Ronner E.; Kuijper A.; Strikwerda S.; Van Kempen W.; Gijsbers S.; Oude Ophuis A.; Swart H.; Hoogenberg K.; Hovens M.; van Hessen M.; Westerink J.; Kragten J.; Nierop P.; Bax W.; Hartong S.; Nieuwdorp M.; Gonkel F.; Al Windy N.; Troquay R.; Schaafsma H.; Lieverse A.; Knufman N.; Tirador L.; Guenon M.; Ferrolino A.; Atilano A.; Aportadera M.; Que M.; Denopol M.; Tolentino M.; Jimeno C.; Wee J.; Mirasol R.; Panelo A.; Roxas D.; Abola M.; Palmes P.; Silva A.; Salvador D.; Rosita R.; Maravilla L.; Rogelio G.; Pacheco E.; Tin Hay L.; Prado J.; Krzy?ag?rska E.; Witek R.; Mik?aszewicz B.; Sudnik W.; Pomie?ko W.; Bochenek A.; Fares I.; Wujkowski M.; Korol M.; Powier?a S.; Goch A.; Mi?kus P.; Siegel A.; Skierkowska J.; Roma?czuk P.; Cygler J.; ?anda K.; Szyprowska E.; Stachlewski P.; Czerski T.; Paw?owicz L.; Sowi?ski D.; Romanowski L.; Rudzki H.; Sk?rski M.; Jasiel-Wojculewicz H.; Stasiewski A.; Kania G.; Mirek-Bryniarska E.; Wojnowski L.; Korzeniak R.; Oh T.; Park K.; Lee M.; Lee K.; Jang H.; Kim S.; Ku B.; Cha B.; Son H.; Lee I.; Park J.; Yu S.; Shon H.; Rhee E.; Cho J.; Park T.; Nam J.; Pintilei E.; Popescu A.; Nafornita V.; Gutu O.; Dumitrescu A.; Bala C.; Caceaune E.; Mindrescu N.; Morosanu M.; Bradescu O.; Munteanu M.; Voitec M.; Vlaiculescu M.; Hancu N.; Diaconu Sotropa M.; Lupu S.; Mateescu A.; Carlan L.; Marton R.; Lupusoru D.; Mot A.; Coman A.; Zaharie D.; Rebrov A.; Shutemova E.; Bolieva L.; Khalimov Y.; Statsenko M.; Galyavich A.; Koziolova N.; Shapovalova Y.; Pavlysh E.; Strongin L.; Vertkin A.; Vishneva E.; Pavlova M.; Khasanov N.; Antsiferov M.; Gavrisheva I.; Sokolova N.; Vorobyev S.; Morugova T.; Sinitsina I.; Ezhov A.; Kobalava Z.; Belenkiy D.; Supryadkina T.; Kazakov Y.; Oschepkova E.; Dreval A.; Novikova T.; Vishnevsky A.; Chizhov D.; Akatova E.; Vorokhobina N.; Ivanov I.; Dudinskaya E.; Konstantinov V.; Kanderkov? D.; Pavl?k L.; Ra?lov? K.; Paulovi? V.; Bab?kov? J.; Bele?ov? K.; Mer?iakov? M.; Truban J.; Vargov? A.; F?bryov? L.; Slovensk? M.; Pl??il R.; Tom??ov? L.; Koll?rov? D.; Spodniakov? D.; Ko??kov? M.; D?uponov? J.; Kur?ov? I.; Skripova D.; Gabri?ov? A.; Kalinov? S.; Ranjith N.; Burgess L.; Mitha I.; Conradie M.; Distiller L.; Pillai P.; Pillay S.; Horak A.; Nethononda R.; van den Berg E.; Nortje H.; Bayat J.; Corbett C.; Abelson M.; van Zyl L.; Pillay T.; Wing J.; Kapp C.; Hidalgo Urbano R.; Gonzalez Juanatey J.; Blanco Coronado J.; Bruguera Cortada J.; Ferreiro Gutierrez J.; Quesada Simon M.; Castro A.; Delgado ?lvarez E.; Freixa R.; Boada A.; Larnefeldt H.; Mooe T.; Koskinen P.; Lagerb?ck P.; Linderfalk C.; Liu B.; Berndtsson Blom K.; Tengmark B.; Lindholm C.; ?stgren C.; Oweling M.; Albertsson P.; Alvarsson M.; Fant S.; Berglund O.; Hsia C.; Chiang C.; Fang C.; Ueng K.; Wang K.; Lai W.; Mamanasiri S.; Wongvipaporn C.; Kuanprasert S.; Thongsri T.; Srimahachota S.; Boonyavarakul A.; Suwanwalaikorn S.; Tantiwong P.; Sritara P.; Sriwijitkamol A.; Sanguanwong S.; Chotinaiwattarakul C.; Piyayotai D.; Balci M.; Orbay E.; Saygili F.; Oguz A.; Altuntas Y.; Comlekci A.; Karpenko O.; Tkach S.; Vlasenko M.; Fushtey I.; Pertseva T.; Reshotko D.; Mostovoy Y.; Vizir V.; Kraiz I.; Amosova K.; Batushkin V.; Tseluyko V.; Koval O.; Strang C.; Bodalia B.; Pieters R.; Turner W.; Asamoah-Owusu N.; White C.; Calvert J.; McNally D.; Jones N.; McKaig G.; Thompson J.; Mohr S.; Simpson H.; Conn P.; McCoye A.; Rivero O.; Yazdani S.; Ince C.; Zeitlin J.; Wharton T.; Platt G.; Anderson R.J.; Angueira-Serrano E.; Lillestol M.; Hanlon B.; Soufer J.; Garcia B.; Iteld B.; Venugopal C.; Ahmed A.; Duardo-Guerra Y.; Jetty P.; Miranda A.; Wahlen J.; Lederman S.; Cohen K.; Lake L.; French W.J.; Tahirkheli N.; Baker S.; Stoltz R.; Wilson J.; Nadar V.; Brown J.; Larrain G.; Wiseman A.; Ruoff G.; Williams M.; Tan A.; Hartman I.; Singh N.; Graf R.; Wakefield P.; McNeill R.; Byars W.; Reyes Almodovar R.; Jones S.; Kantaros L.; Hegedosh N.; Graves M.; Bernstein M.; Falkowski S.; Bialow M.; Paraschos A.; Dagher G.; Arif A.; Condit J.; Chaykin L.; Grunstra B.; Earl J.; Unks D.; Srivastava S.; Benson M.; Huffman C.; Miller G.; Willis J.; Bender K.; Martin E.; Blackmore R.; Rohr K.; Chilka S.; Gadowski G.; Fitz-Patrick D.; Benjamin S.; Morin D.; Zias Dilena A.; Acosta R.; Claassen D.; Miranda F.; Raad G.; Inzerello A.; Porter J.; Bhattacharya A.; Gutmann J.; Korpas D.; Syed M.; Zieve F.; Raisinghani A.; Alam S.; Bartkowiak A.; Boccalandro F.; Talano J.; Mercado A.; Krichmar P.; Oldfield C.; Adams K.; Gorman T.; Lewis D.; Shah R.; Shockey G.; Lefebvre G.; Andrawis N.; Tami L.; Bittar N.; Khan M.S.; Rink L.; Hendrix E.; Wood J.; Robinson J.; Pavon H.; Irfan M.; Gonzalez E.; Singal R.; Shore K.; Saba F.; Bianco J.; Erickson B.; Gorson D.; Puri S.; Arauz-Pacheco C.; Forman S.; Akyea-Djamson A.; Lieber I.; Barker B.; Desai P.; Sotolongo C.; Steinhoff J.; Hill R.; Radin M.; Patel R.; Lieberman S.; Wenocur H.; Dagogo-Jack S.; Lupovitch S.; Ison R.; Bacharach J.M.; Diogo J.; Mazzella M.; Greenwald J.; Quadrel M.; Mayer N.; Datu J.; McCartney M.; Bruce T.; Singal D.; Turner J.; Videau B.; Fritz R.; Fox D.; Calatayud G.; Sheldon W.; Kereiakes D.; Thomas J.; Salacata A.; McCullum K.; Harris B.; de Souza J.; Rahman A.; Blumenthal S.; Narayan P.; Bloch M.; Augenbraun C.; Bernstein R.; Perlman R.; Berman J.; LaBryer L.; Wynne A.; Fish J.; Zarich S.; Gabra N.; Popeil L.; Hermany P.; Barreto A.; Pomposini D.; Gonzalez-Campoy J.M.; Langer M.; Bayron C.; Suneja R.; Kamlet J.; Wheeler K.; Hurley S.; Sharma S.; Wefald F.; Hershon K.; O'Connor T.; Pueblitz G.; Laguerre J.; Amin M.; Alfonso T.; Jaffrani N.; Isserman S.; Portnay E.; Vlastaris A.; Dy J.; Hagan M.; Noveck H.; Kraft P.; Andersen J.; Foley B.; Carr K.; Gelormini J.; Williams T.; Landau C.; Richwine R.; Thakkar M.; Karim A.; Madhun Z.; Francyk D.; Lamantia J.; Baker B.; Zhang W.; Lev V.; Hasan M.; Captain A.; Herzog W.; Friedman K.; Lawson W.; Desai V.; Ow C.; Simons R.; Mandviwala M.; Le T.; Hack T.; Zebrack J.; Henderson D.; DeJulia J.; Mehta R.; Reza S.; Poonawala R.; Awad A.; Velasquez M.; Mohiuddin S.; Salazar Sharma M.; Myrick G.; Gottlieb D.; Ovalle F.; Alfieri A.; Ahmed S.; Bohula E.; Donahoe S.M.; Longshaw K.; Eshaghian S.; Lash J.; Goldberg R.K.; Fox B.; Mostel E.; Dobies D.; Ward H.; Burbano J.; Puleo P.; Lenhard M.J.; Korn D.; Thadani U.; Bradley A.; Kmetzo J.; Heasley E.; Raikhel M.; Mahr N.; Bittar G.; Fuentes F.; Raghu P.; Diep T.T.B.; Tran Q.K.; Tran N.; Nguyen D.; Nguy?n V.; DECLARE-TIMI 58 Investigators |
| 臺大學術典藏 |
2021-04-23T05:56:32Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
|
Park K.;Vansteenkiste J.;Lee K.H.;Pentheroudakis G.;Zhou C.;Prabhash K.;Seto T.;Voon P.J.;Tan D.S.W.;Chih-Hsin Yang;Wang J.;Babu K.G.;Nakayama Y.;Alip A.;Chua K.L.M.;Cheng J.C.-H.;Senan S.;Ahn Y.C.;Kim T.-Y.;Ahn H.K.;Peters S.;Yoshino T.;Douillard J.-Y.; Park K.; Vansteenkiste J.; Lee K.H.; Pentheroudakis G.; Zhou C.; Prabhash K.; Seto T.; Voon P.J.; Tan D.S.W.; CHIH-HSIN YANG; Wang J.; Babu K.G.; Nakayama Y.; Alip A.; Chua K.L.M.; Cheng J.C.-H.; Senan S.; Ahn Y.C.; Kim T.-Y.; Ahn H.K.; Peters S.; Yoshino T.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-04-23T05:56:29Z |
Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations: A Database of 693 Cases
|
Chih-Hsin Yang;Schuler M.;Popat S.;Miura S.;Heeke S.;Park K.;M?Rten A.;Kim E.S.; CHIH-HSIN YANG; Schuler M.; Popat S.; Miura S.; Heeke S.; Park K.; M?rten A.; Kim E.S. |
| 臺大學術典藏 |
2021-04-23T05:56:27Z |
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
|
Wu Y.-L.;Cheng Y.;Zhou J.;Lu S.;Zhang Y.;Zhao J.;Kim D.-W.;Soo R.A.;Kim S.-W.;Pan H.;Chen Y.-M.;Chian C.-F.;Liu X.;Tan D.S.W.;Bruns R.;Straub J.;Johne A.;Scheele J.;Park K.;Chih-Hsin Yang;Liu Z.;Chen X.;Wang M.;Yu S.;Zhang H.;Fang J.;Li W.;Yang C.-H.;Chang G.-C.;Hsia T.-C.;Yang C.-T.;Wang C.-C.;Cho B.C.;Lee K.H.;Kim Y.-C.;An H.J.;Woo I.S.;Cho J.Y.;Shin S.W.;Lee J.-S.;Kim J.-H.;Yoo S.S.;Kato T.;Shinagawa N.;Tan S.W.D.;Ngo L.S.-M.;Ratnavelu K.;Ahmad A.R.;Liam C.K.;De Marinis F.;Tassone P.;Molla A.I.;Calles Blanco A.;Lazaro Quintela M.E.;Felip Font E.;Dingemans A.-M.;Bui L.; Wu Y.-L.; Cheng Y.; Zhou J.; Lu S.; Zhang Y.; Zhao J.; Kim D.-W.; Soo R.A.; Kim S.-W.; Pan H.; Chen Y.-M.; Chian C.-F.; Liu X.; Tan D.S.W.; Bruns R.; Straub J.; Johne A.; Scheele J.; Park K.; CHIH-HSIN YANG; Liu Z.; Chen X.; Wang M.; Yu S.; Zhang H.; Fang J.; Li W.; Yang C.-H.; Chang G.-C.; Hsia T.-C.; Yang C.-T.; Wang C.-C.; Cho B.C.; Lee K.H.; Kim Y.-C.; An H.J.; Woo I.S.; Cho J.Y.; Shin S.W.; Lee J.-S.; Kim J.-H.; Yoo S.S.; Kato T.; Shinagawa N.; Tan S.W.D.; Ngo L.S.-M.; Ratnavelu K.; Ahmad A.R.; Liam C.K.; de Marinis F.; Tassone P.; Molla A.I.; Calles Blanco A.; Lazaro Quintela M.E.; Felip Font E.; Dingemans A.-M.; Bui L. |
| 臺大學術典藏 |
2021-04-23T05:56:25Z |
Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non�Vsmall Cell Lung Cancer
|
Yu H.A.;Paz-Ares L.G.;Chih-Hsin Yang;Lee K.H.;Garrido P.;Park K.;Kim J.-H.;Lee D.H.;Mao H.;Wijayawardana S.R.;Gao L.;Hozak R.R.;Chao B.H.;Planchard D.; Yu H.A.; Paz-Ares L.G.; CHIH-HSIN YANG; Lee K.H.; Garrido P.; Park K.; Kim J.-H.; Lee D.H.; Mao H.; Wijayawardana S.R.; Gao L.; Hozak R.R.; Chao B.H.; Planchard D. |
| 臺大學術典藏 |
2021-04-23T05:56:23Z |
Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial
|
Park K.;?Zg?Ro?Lu, Mustafa;Vansteenkiste J.;Spigel D.;Chih-Hsin Yang;Bajars M.;Ruisi M.;Manitz J.;Barlesi F.; Park K.; ?zg?ro?lu, Mustafa; Vansteenkiste J.; Spigel D.; CHIH-HSIN YANG; Bajars M.; Ruisi M.; Manitz J.; Barlesi F. |
| 中山醫學大學 |
2021 |
Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study
|
Park, K; Janne, PA; Kim, DW; Han, JY; Wu, MF; Lee, JS; Kang, JH; Lee, DH; Cho, BC; Yu, CJ; Pang, YK; Felip, E; Kim, H; Baek, E; Noh, YS |
| 中山醫學大學 |
2021 |
Phase I results of S49076 plus gefitinib in patients with EGFR TKI-resistant non-small cell lung cancer harbouring MET/AXL dysregulation
|
Park, K; Chang, GC; Curigliano, G; Lim, WT; Soo, RA; Molina-Vila, MA; Cattan, V; Darville, H; Gandossi, E; Smutna, V; Sudey, I; Viteri, S |
| 中山醫學大學 |
2021 |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
|
Chang, GC; Lam, DCL; Tsai, CM; Chen, YM; Shih, JY; Aggarwal, S; Wang, SH; Kim, SW; Kim, YC; Wahid, I; Li, RB; Lim, DWT; Sriuranpong, V; Chan, RTT; Lorence, RM; Carriere, P; Raabe, C; Cseh, A; Park, K |
| 國立成功大學 |
2021 |
Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors
|
Park, K.;Tan, D.S.W.;Su, W.-C.;Cho, B.C.;Kim, S.-W.;Lee, K.H.;Wang, C.-C.;Seto, T.;Huang, D.C.-L.;Jung, H.H.;Hsu, M.-C.;Bogenrieder, T.;Lin, C.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:40Z |
East Asian subgroup analysis of a randomized, double-blind, phase 3 study of docetaxel and ramucirumab versus docetaxel and placebo in the treatment of stage IV non-small cell lung cancer following disease progression after one prior platinum-based therapy (REVEL)
|
Orlando M.; Puri T.; Alexandris E.; Lee P.; Zimmermann A.H.; Cho E.K.; Kang J.-H.; JIN-YUAN SHIH; Kim J.-H.; Park K. |
| 臺大學術典藏 |
2020-08-13T06:33:24Z |
The relevance of docetaxel-related febrile neutropenia to patient-reported symptoms and the quality of life in Japanese, East Asian (Korean, Taiwanese), and Non-east asian patients based on post-hoc analyses of two randomized clinical trials of docetaxel with and without anti-angiogenic agent in advanced non-small cell lung cancer after progression on platinum-based chemotherapy
|
Inoue A.; Omori Y.;Enatsu S.;Brnabic A.J.M.;Rajan N.;Jin-Yuan Shih;Kim J.-H.;Park K.;Inoue A.; Omori Y.; Enatsu S.; Brnabic A.J.M.; Rajan N.; JIN-YUAN SHIH; Kim J.-H.; Park K. |
| 臺大學術典藏 |
2020-05-26T09:27:18Z |
Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in east asian patients with advanced non-small cell lung cancer: Results of an exploratory subgroup analysis of a phase III trial
|
Chih-Hsin Yang;Simms L;Park K;Lee J.S;Scagliotti G;Orlando M.; CHIH-HSIN YANG; Simms L; Park K; Lee J.S; Scagliotti G; Orlando M. |
| 臺大學術典藏 |
2020-05-26T09:27:11Z |
INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer
|
Wu Y.-L;Park K;Soo R.A;Sun Y;Tyroller K;Wages D;Ely G;Chih-Hsin Yang;Mok T.; Wu Y.-L; Park K; Soo R.A; Sun Y; Tyroller K; Wages D; Ely G; CHIH-HSIN YANG; Mok T. |
| 臺大學術典藏 |
2020-05-26T09:27:07Z |
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): A phase 2b/3 randomised trial
|
Chih-Hsin Yang;Lorence R.M;Cong X.J;Shahidi M;Chao T.-Y;Tan E.-H;Crino L;Heo D.S;Sun Y;Wang M;Su W.-C;Zhou C;Kim S.-W;Park K;Chen Y.-M;Cadranel J;Hirsh V;Miller V.A; Miller V.A; Hirsh V; Cadranel J; Chen Y.-M; Park K; Kim S.-W; Zhou C; Su W.-C; Wang M; Sun Y; Heo D.S; Crino L; Tan E.-H; Chao T.-Y; Shahidi M; Cong X.J; Lorence R.M; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:26:59Z |
First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial
|
CHIH-HSIN YANG; Kang J.H; Mok T; Ahn M.-J; Srimuninnimit V; Lin C.-C; Kim D.-W; Tsai C.-M; Barraclough H; Altug S; Orlando M; Park K. |
| 臺大學術典藏 |
2020-05-26T09:26:51Z |
A randomized phase 2 study comparing the combination of ficlatuzumab and gefitinib with gefitinib alone in asian patients with advanced stage pulmonary adenocarcinoma
|
Park K.;Close S;Garrus J.E;Payumo F;Komarnitsky P;Han M;Chang G.-C;Chih-Hsin Yang;Tan E.-H;Su W.-C;Geater S.L;Mok T.S.K; Mok T.S.K; Geater S.L; Su W.-C; Tan E.-H; CHIH-HSIN YANG; Chang G.-C; Han M; Komarnitsky P; Payumo F; Garrus J.E; Close S; Park K. |
| 臺大學術典藏 |
2020-05-26T09:26:49Z |
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: Phase III randomized LUX-Lung 5 trial
|
Lux-Lung 5 Investigators;Serwatowski P;Kazarnowicz A;Jaskiewicz P;Palomino O.L.M;Pantigoso W.R;Barreda R.L.A;S?nchez J.F.S;Gans S;Herder G;Dingemans A.-M;Stigt J;Aerts J;Baca O.P;Luna G.A;Perez J.L.G;Delgado F.G;Cruciani G;Ceresoli G.L;Platania M;Milandri C;Gridelli C;Bearz A;Bidoli P;Migliorino M.R;Stemmer S;Gottfried M;Onn A;Nagarkar R.V;Dadhich H;Sharma L;Venkatesan S;Jain M;Prabhash K;Sarosi V;Strausz J;Tehenes S;Mark Z;Wiewrodt R;Dickgreber N;Huber R;Von Pawel J;Laack E;Keilholz U;Faehling M;Wehler T;Thomas M;Coudert B;Rotarski M;Gervais R;Fournel P;Bennouna J;Planchard D;Perol M;Sibilot D.M;Zalcman G;Chouaid C;Cadranel J;Alanko T;Riska H;Zadra C.A;Garicochea B;Zereu M;Lu S;Zhang Y;Huang J;Feng J;Qin S;Cheng Y;Liu X;Wu Y;Lin X;Thropay J;Meza L;Gurtler J;Summers Y;Upadhyay S;Brown E;Talbot T;Toy E;Spicer J;Popat S;Mitra S;Shah R;Polishchuk I;Bondarenko I;Ponomarova O;Popovych O;Vinnyk Y;Hsieh R.-K;Ho C.-L;Huang M.-S;Su W.-C;Tsao T.C.-Y;Chang G.-C;Tsai Y.-H;Chen Y.-M;Hsia T.-C;Yang C.-H;Kim Y.-C;Han J.-Y;Kim J.-H;Park K;Kim S.-W;Kim D.-W;Felip E;Cobo M;Lianes P;Campelo R.G;Camps C;Larriba J.L.G;Garrido P;Ragulin Y;Orlov S;Karaseva N;Lubennikov V;Jassem J;Szczesna A;Huang C;Wang J;Zhou C;Vercauter P;Delval L;Lambrechts M;Galdermans D;Carestia L;Bustin F;Humblet Y;Greil R;Mainwaring P;Crombie C;Underhill C;Parente P;Mclachlan S.-A;Richardet M;Blajman C;Zarba J.J;Recondo G;Martin C.M;Bagnes C;Planchard D;Chand V.K;Wang B;Zhou C;Wiewrodt R;Vinnyk Y;Strausz J;Lu S;Liu X;Kim D.-W;Grossi F;Feng J.-F;De Marinis F;Chouaid C;Chen Y.-M;Bennouna J;Kim J.-H;Park K;Chih-Hsin Yang;Schuler M; Zadra C.A; Riska H; Alanko T; Cadranel J; Chouaid C; Zalcman G; Sibilot D.M; Perol M; Planchard D; Bennouna J; Fournel P; Gervais R; Rotarski M; Coudert B; Thomas M; Wehler T; Faehling M; Keilholz U; Laack E; Von Pawel J; Huber R; Dickgreber N; Wiewrodt R; Mark Z; Tehenes S; Strausz J; Sarosi V; Prabhash K; Jain M; Venkatesan S; Sharma L; Dadhich H; Nagarkar R.V; Onn A; Gottfried M; Stemmer S; Migliorino M.R; Bidoli P; Bearz A; Gridelli C; Milandri C; Platania M; Ceresoli G.L; Cruciani G; Delgado F.G; Perez J.L.G; Luna G.A; Baca O.P; Aerts J; Stigt J; Dingemans A.-M; Herder G; Gans S; Sánchez J.F.S; Barreda R.L.A; Pantigoso W.R; Palomino O.L.M; Jaskiewicz P; Kazarnowicz A; Serwatowski P; Szczesna A; Jassem J; Lubennikov V; Karaseva N; Orlov S; Ragulin Y; Garrido P; Larriba J.L.G; Camps C; Campelo R.G; Lianes P; Cobo M; Felip E; Kim D.-W; Kim S.-W; Park K; Kim J.-H; Han J.-Y; Kim Y.-C; Yang C.-H; Hsia T.-C; Chen Y.-M; Tsai Y.-H; Chang G.-C; Tsao T.C.-Y; Su W.-C; Huang M.-S; Ho C.-L; Hsieh R.-K; Vinnyk Y; Popovych O; Ponomarova O; Bondarenko I; Polishchuk I; Shah R; Mitra S; Popat S; Spicer J; Toy E; Talbot T; Brown E; Upadhyay S; Summers Y; Gurtler J; Meza L; Thropay J; LUX-Lung 5 Investigators; Schuler M; CHIH-HSIN YANG; Park K; Kim J.-H; Bennouna J; Chen Y.-M; Chouaid C; De Marinis F; Feng J.-F; Grossi F; Kim D.-W; Liu X; Lu S; Strausz J; Vinnyk Y; Wiewrodt R; Zhou C; Wang B; Chand V.K; Planchard D; Bagnes C; Martin C.M; Recondo G; Zarba J.J; Blajman C; Richardet M; McLachlan S.-A; Parente P; Underhill C; Crombie C; Mainwaring P; Greil R; Humblet Y; Bustin F; Carestia L; Galdermans D; Lambrechts M; Delval L; Vercauter P; Zhou C; Wang J; Huang C; Lin X; Wu Y; Liu X; Cheng Y; Qin S; Feng J; Huang J; Zhang Y; Lu S; Zereu M; Garicochea B |
| 臺大學術典藏 |
2020-05-26T09:26:48Z |
Gefitinib maintenance therapy versus gefitinib monotherapy in east asian never-smoker patients with locally advanced or metastatic nonsquamous non-small cell lung cancer: Final overall survival results from a randomized phase 3 study
|
Park K.;Wang X;Puri T;Orlando M;Mok T;Tsai C.-M;Kim S.-W;Lin C.-C;Ahn M.-J;Srimuninnimit V;Chih-Hsin Yang; CHIH-HSIN YANG; Srimuninnimit V; Ahn M.-J; Lin C.-C; Kim S.-W; Tsai C.-M; Mok T; Orlando M; Puri T; Wang X; Park K. |
| 臺大學術典藏 |
2020-05-26T09:26:47Z |
140PD: LUX-Lung 7: A Phase IIb, global, randomised, open-label trial of afatinib vs gefitinib as first-line treatment for patients (pts) with advanced non-small cell lung cancer (NSCLC) harbouring activating EGFR mutations
|
Mok T; Kim M; Paz-Ares L.; Paz-Ares L.;Kim M;Mok T;Chih-Hsin Yang;Boyer M;O'Byrne K;Hirsh V;Zhang L;Tan E.-H;Park K; Park K; Tan E.-H; Zhang L; Hirsh V; O'Byrne K; Boyer M; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:26:45Z |
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): A phase 2B, open-label, randomised controlled trial
|
Paz-Ares L.;Zazulina V;Massey D;Kim M;Shahidi M;Tsai C.-M;Laurie S.A;K?lbeck K;Arvis C.D;Kim D.-W;Laskin J;Kim S.-W;Shi Y;Lu S;Lee K.H;Chih-Hsin Yang;Hirsh V;Mok T;Boyer M;Zhang L;O'Byrne K;Tan E.-H;Park K; Park K; Tan E.-H; O'Byrne K; Zhang L; Boyer M; Mok T; Hirsh V; CHIH-HSIN YANG; Lee K.H; Lu S; Shi Y; Kim S.-W; Laskin J; Kim D.-W; Arvis C.D; Kölbeck K; Laurie S.A; Tsai C.-M; Shahidi M; Kim M; Massey D; Zazulina V; Paz-Ares L. |
| 臺大學術典藏 |
2020-05-26T09:26:42Z |
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: Overall survival data from the phase IIb LUX-Lung 7 trial
|
Mok T; Lee K.H; Lu S; Shi Y; Lee D.H; Laskin J; Kim D.-W; Laurie S.A; Kölbeck K; Fan J; Dodd N; Märten A; Park K.; Park K.;M?rten A;Dodd N;Fan J;K?lbeck K;Laurie S.A;Kim D.-W;Laskin J;Lee D.H;Shi Y;Lu S;Lee K.H;Mok T;Chih-Hsin Yang;Boyer M;Hirsh V;Zhang L;O'Byrne K;Tan E.-H;Paz-Ares L; Paz-Ares L; Tan E.-H; O'Byrne K; Zhang L; Hirsh V; Boyer M; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:26:35Z |
Phase III, randomized, placebo-controlled, double-blind trial of motesanib (AMG-706) in combination with paclitaxel and carboplatin in east asian patients with advanced nonsquamous non-small-cell lung cancer
|
Chih-Hsin Yang;Lin C.-B;Lee K.-H;Cho E.K;Park K;Tanaka H;Ichinose Y;Yamada K;Kato T;Kaneda H;Hayashi H;Nakagawa K;Yoh K;Hida T;Oshita F;Yoshioka H;Hara K;Asato T;Kubota K; Kubota K; Asato T; Hara K; Yoshioka H; Oshita F; Hida T; Yoh K; Nakagawa K; Hayashi H; Kaneda H; Kato T; Yamada K; Ichinose Y; Tanaka H; Park K; Cho E.K; Lee K.-H; Lin C.-B; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:26:33Z |
A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non?�Small-Cell Lung Cancer
|
Park K.;Puri T;Orlando M;Han B;Mok T;Chih-Hsin Yang; CHIH-HSIN YANG; Mok T; Han B; Orlando M; Puri T; Park K. |
| 臺大學術典藏 |
2020-05-26T09:26:29Z |
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
|
Havel L; Pauk N; Singh J; Murakami S; Garassino M.C; Cho B.-C; Kim J.-H; Mazières J; Vansteenkiste J; Lena H; Corral Jaime J; Gray J.E; Powderly J; Chouaid C; Bidoli P; Wheatley-Price P; Park K; Soo R.A; Huang Y; Wadsworth C; Dennis P.A; Rizvi N.A; Paz-Ares Rodriguez L; Novello S; Hiret S; Schmid P; Laack E; Califano R; Maemondo M; Kim S.-W; Chaft J; Vicente Baz D; Berghmans T; Kim D.-W; Surmont V; Reck M; Han J.-Y; Holgado Martin E; Belda Iniesta C; Oe Y; Chella A; Chopra A; Robinet G; Soto Parra H; Thomas M; Cheema P; Katakami N; Su W.-C; Kim Y.-C; Wolf J; Lee J.-S; Saka H; Milella M; Ramos Garcia I; Sibille A; Yokoi T; Kang E.J; Atagi S; Spaeth-Schwalbe E; Nishio M; Imamura F; Gabrail N; Veillon R; Derijcke S; Maeda T; Zylla D; Kubiak K; Santoro A; Uy M.N; Lucien Geater S; Italiano A; Kowalski D; Barlesi F; Chen Y.-M; Spigel D; Chewaskulyong B; Garcia Gomez R; Alvarez Alvarez R; CHIH-HSIN YANG; Hsia T.-C; Denis F; Sakai H; Vincent M; Goto K; Bosch-Barrera J; Weiss G; Canon J.-L; Scholz C; Aglietta M; Kemmotsu H; Csoszi T; Losonczy G; Price A; Anderson I; Iqbal M; Torri V; Juhasz E; Khanani S; Koubkova L; Levy B; Page R; Bocskei C; Crinò L; Einspahr D; Hagenstad C; Juat N; Overton L; Garrison M; Szalai Z; ATLANTIC Investigators; Azuma K; Bradbury P; Feld R; Chachoua A; Jassem J; Juergens R; Palmero Sanchez R; Malcolm A; Vrindavanam N; Kubota K; Waller C; Waterhouse D; Coudert B; Mark Z; Satouchi M; Chang G.-C; Herzmann C; Chaudhry A; Giridharan S; Hesketh P; Ikeda N; Boccia R; Iannotti N; Haigentz M; Reynolds J; Querol J; Nakagawa K; Sugawara S; Tan E.H; Hirashima T; Gettinger S; Kato T; Takeda K; Juan Vidal O; Mohn-Staudner A; Panwalkar A; Daniel D; Kobayashi K; Ladrera G.E.I; Schulte C; Sebastian M; Cernovska M; Coupkova H; Juat N;Hagenstad C;Einspahr D;Crin? L;Bocskei C;Page R;Levy B;Koubkova L;Khanani S;Juhasz E;Torri V;Iqbal M;Anderson I;Price A;Losonczy G;Csoszi T;Murakami S;Singh J;Pauk N;Havel L;Coupkova H;Cernovska M;Sebastian M;Schulte C;Ladrera G.E.I;Kobayashi K;Daniel D;Panwalkar A;Mohn-Staudner A;Juan Vidal O;Takeda K;Kato T;Gettinger S;Hirashima T;Tan E.H;Sugawara S;Nakagawa K;Querol J;Reynolds J;Haigentz M;Iannotti N;Boccia R;Ikeda N;Hesketh P;Giridharan S;Chaudhry A;Herzmann C;Chang G.-C;Satouchi M;Mark Z;Coudert B;Waterhouse D;Waller C;Kubota K;Vrindavanam N;Malcolm A;Palmero Sanchez R;Juergens R;Jassem J;Chachoua A;Feld R;Bradbury P;Azuma K;Kemmotsu H;Aglietta M;Scholz C;Canon J.-L;Weiss G;Bosch-Barrera J;Goto K;Vincent M;Sakai H;Denis F;Hsia T.-C;Chih-Hsin Yang;Alvarez Alvarez R;Garcia Gomez R;Chewaskulyong B;Spigel D;Chen Y.-M;Barlesi F;Kowalski D;Italiano A;Lucien Geater S;Uy M.N;Santoro A;Kubiak K;Zylla D;Maeda T;Derijcke S;Veillon R;Gabrail N;Imamura F;Nishio M;Spaeth-Schwalbe E;Atagi S;Kang E.J;Yokoi T;Sibille A;Ramos Garcia I;Milella M;Saka H;Lee J.-S;Wolf J;Kim Y.-C;Su W.-C;Katakami N;Atlantic Investigators;Szalai Z;Garrison M;Overton L;Cheema P;Thomas M;Soto Parra H;Robinet G;Chopra A;Chella A;Oe Y;Belda Iniesta C;Holgado Martin E;Han J.-Y;Reck M;Surmont V;Kim D.-W;Berghmans T;Vicente Baz D;Chaft J;Kim S.-W;Maemondo M;Califano R;Laack E;Schmid P;Hiret S;Novello S;Paz-Ares Rodriguez L;Rizvi N.A;Dennis P.A;Wadsworth C;Huang Y;Soo R.A;Park K;Wheatley-Price P;Bidoli P;Chouaid C;Powderly J;Gray J.E;Corral Jaime J;Lena H;Vansteenkiste J;Mazi?res J;Kim J.-H;Cho B.-C;Garassino M.C |
| 臺大學術典藏 |
2020-05-26T09:26:27Z |
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials
|
Park K.;Paz-Ares L; Chih-Hsin Yang;M?rten A;Peil B;Mok T;Boyer M;O'Byrne K;Yamamoto N;Hirsh V;Schuler M;Barrios C.H;Kato T;Tsai C.-M;Lee K.H;Zhang L;Orlov S;Geater S.L;Tan E.-H;Sequist L.V;Wu Y.-L; Wu Y.-L; Sequist L.V; Tan E.-H; Geater S.L; Orlov S; Zhang L; Lee K.H; Tsai C.-M; Kato T; Barrios C.H; Schuler M; Hirsh V; Yamamoto N; O'Byrne K; Boyer M; Mok T; Peil B; Märten A; Chih-Hsin CHIH-HSIN YANG; Paz-Ares L; Park K. |
| 臺大學術典藏 |
2020-05-26T09:26:26Z |
Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations
|
Nakagawa K.;Fukuoka M;Morita S;Shimazaki M;Kaneko Y;Akazawa R;Takeda K;Nakagawa T;Kang J.-H;Takeda K;Inoue A;Kiura K;Kim S.-W;Nishio M;Chih-Hsin Yang;Tsai C.-M;Azuma K;Park K;Seto T;Hayashi H;Nokihara H;Murakami H; Murakami H; Nokihara H; Hayashi H; Seto T; Park K; Azuma K; Tsai C.-M; CHIH-HSIN YANG; Nishio M; Kim S.-W; Kiura K; Inoue A; Takeda K; Kang J.-H; Nakagawa T; Takeda K; Akazawa R; Kaneko Y; Shimazaki M; Morita S; Fukuoka M; Nakagawa K. |
| 臺大學術典藏 |
2020-05-26T09:26:22Z |
Pan-asian adapted clinical practice guidelines for the management of patients with metastatic non-small-cell lung cancer: A csco-esmo initiative endorsed by jsmo, ksmo, mos, sso and tos
|
Chang J.W.C; Alip A; Peters S; Douillard J.-Y.; Soo R.A; Park K; Mitsudomi T; Azrif M; CHIH-HSIN YANG; Tan D.S.W; Kim D.-W; Wu Y.-L;Planchard D;Lu S;Sun H;Yamamoto N;Kim D.-W;Tan D.S.W;Chih-Hsin Yang;Azrif M;Mitsudomi T;Park K;Soo R.A;Chang J.W.C;Alip A;Peters S;Douillard J.-Y.; Wu Y.-L; Planchard D; Lu S; Sun H; Yamamoto N |
| 臺大學術典藏 |
2020-05-26T09:26:22Z |
First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the ?�real-world??clinical setting
|
Park K;Wan-Teck Lim D;Okamoto I;Chih-Hsin Yang; Park K; Wan-Teck Lim D; Okamoto I; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:26:21Z |
Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer
|
Park K;Bennouna J;Boyer M;Hida T;Hirsh V;Kato T;Lu S;Mok T;Nakagawa K;O'Byrne K;Paz-Ares L;Schuler M;Sibilot D.M;Tan E.-H;Tanaka H;Wu Y.-L;Chih-Hsin Yang;Zhang L;Zhou C;M?rten A;Tang W;Yamamoto N.; Park K; Bennouna J; Boyer M; Hida T; Hirsh V; Kato T; Lu S; Mok T; Nakagawa K; O'Byrne K; Paz-Ares L; Schuler M; Sibilot D.M; Tan E.-H; Tanaka H; Wu Y.-L; CHIH-HSIN YANG; Zhang L; Zhou C; Märten A; Tang W; Yamamoto N. |
| 臺大學術典藏 |
2020-05-26T09:26:20Z |
First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression
|
Schuler M;Tan E.-H;O??Byrne K;Zhang L;Boyer M;Mok T;Hirsh V;Chih-Hsin Yang;Lee K.H;Lu S;Shi Y;Kim S.-W;Laskin J;Kim D.-W;Arvis C.D;K?lbeck K;Massey D;M?rten A;Paz-Ares L;Park K.; Schuler M; Tan E.-H; O?�Byrne K; Zhang L; Boyer M; Mok T; Hirsh V; CHIH-HSIN YANG; Lee K.H; Lu S; Shi Y; Kim S.-W; Laskin J; Kim D.-W; Arvis C.D; Kölbeck K; Massey D; Märten A; Paz-Ares L; Park K. |
| 臺大學術典藏 |
2020-05-26T09:26:20Z |
First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials
|
Schuler M;Paz-Ares L;Sequist L.V;Hirsh V;Lee K.H;Wu Y.-L;Lu S;Zhou C;Feng J;Ellis S.H;Samuelsen C.H;Tang W;M?rten A;Ehrnrooth E;Park K;Chih-Hsin Yang; Schuler M; Paz-Ares L; Sequist L.V; Hirsh V; Lee K.H; Wu Y.-L; Lu S; Zhou C; Feng J; Ellis S.H; Samuelsen C.H; Tang W; Märten A; Ehrnrooth E; Park K; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-25T07:35:22Z |
First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial
|
Chia-Chi Lin; Kim D.-W; Tsai C.-M; Barraclough H; Altug S; Orlando M; Park K.; Srimuninnimit V; Ahn M.-J; Mok T; Kang J.H; Yang J.C.-H |
